<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study describes progression of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ring sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>) of 3 years' duration to B-<z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>Development of ALL in this patient was preceded by the deterioration of dyserythropoiesis, <z:hpo ids='HP_0001882'>leukopenia</z:hpo> and an increase of blasts in the bone marrow </plain></SENT>
<SENT sid="2" pm="."><plain>Our case may represent an additional evidence to the hypothesis that a primary pathogenetic lesion in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> occurs at the level of the pluripotent stem cell </plain></SENT>
</text></document>